SANTHERA PHARMACEUTICALS HOLDING AG CHF0.1 (POST CONS) revenue breakdown overview

SANTHERA PHARMACEUTICALS HOLDING AG CHF0.1 (POST CONS) revenue for the last year amounted to 39.11 M CHF, the most of which — 39.12 M CHF — came from its highest performing source at the moment, Specialty Niche Products, the year earlier bringing 103.41 M CHF. The greatest contribution to the revenue figure was made by Germany — last year it brought SANTHERA PHARMACEUTICALS HOLDING AG CHF0.1 (POST CONS) 12.80 M CHF.